The emergency use authorization has been rescinded as the approval is for seniors and those who are high risk.
The Food and Drug Administration set new limits for the use of COVID-19 vaccines in American patients, rolling back its authorization of the vaccines for use only in patients above the age of 64 and those with at least one underlying health condition. The emergency-use authorization has been terminated, and the immunizations from Moderna, Pfizer, and Novavax have been approved for “those at high risk.“
“The emergency use authorizations for Covid vaccines, once used to justify broad mandates on the general public during the Biden administration, are now rescinded,” Health Secretary Robert F. Kennedy, Jr. announced. “These vaccines are available for all patients who choose them after consulting with their doctors.”
The Department of Health and Human Services stated, “The transition is from a circumstance where vaccines have been marketed under both the emergency use pathway and the traditional approval pathway, to a circumstance where the COVID-19 vaccines are now marketed only under the traditional approval pathway. This is not a removal of COVID-19 vaccines from the market.”
As the Lord Leads, Pray with Us…
- For Secretary Kennedy to be led by God as he updates the policies of the Department of Health and Human Services.
- For Commissioner Makary as he heads the Food and Drug Administration and oversees the approvals of immunizations and treatments.
Sources: UPI News, NPR, USA Today, MSN
